Kurz, Sylvia C.
Wen, Patrick Y.
Article History
First Online: 18 April 2018
Compliance with Ethical Standards
:
: Sylvia C. Kurz declares that she has no conflict of interest. Patrick Y. Wen receives research support from Agios, Angiochem, Astra Zeneca, Exelixis, Genentech/Roche, GlaxoSmith Kline, Karyopharm, Novartis, Sanofi-Aventis, Regeneron Pharmaceutical Inc., and Vascular Biogenics; he is on the advisory board for Abbvie, Cavion, Celldex, Genentech/Roche, Midatech, Momenta, Novartis, Novocure, SigmaTau, and Vascular Biogenics and is part of the Speaker’s Bureau for Merck.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.